The import market

Anyone who has ever purchased pharmaceuticals in other EU-memberstates saw for himself: many branded pharmaceuticals are less expensive there than here in Germany.

As an importer of such pharmaceuticals, EurimPharm takes advantage of the price differences to other EU countries and offers many well-known branded pharmaceuticals at a lower price in Germany. Consequently, we can provide savings of up to 30 percent for patients and health insurance providers. Such parallel imports have to be dispensed by the pharmacies in order to cost reductions.

Parallel import

Pharmaceuticals are produced by multinational pharmaceutical companies abroad and sold in Germany by their German subsidiaries.

EurimPharm purchases the same pharmaceuticals within the EU and offers them at a more affordable price in Germany as imported pharmaceuticals.

Re-import

Pharmaceuticals are produced by multinational pharmaceutical companies in Germany and distributed within the EU by their subsidiaries.

EurimPharm purchases the same pharmaceuticals within the EU and offers them at a more affordable price in Germany as imported pharmaceuticals.

§ Legal framework

The legal basis of pharmaceutical imports are two fundamental principles of the EU:

  • free movement of goods
  • exhaustion of patent and trademark rights

This offers patients, health insurance providers, and politicians the considerable opportunity to benefit from the more affordable EurimPharm imported pharmaceuticals. This potential for savings has been identified. Pharmacies are therefore required to generate a certain percentage of their dispensing with charges of imported pharmaceuticals.

Deutsch Search